Larvol Delta - Development-of-combination-therapies-to-maximize-the-impact-of-KRASG12C-inhibitors-in-lung-cancer

ARS-1620 - Kura Oncology, J&J

http://www.ncbi.nlm.nih.gov/pubmed/31534020

Sep 21, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next